National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

February 10, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 27 (Tuesday, February 10, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 27 (Tuesday, February 10, 2026)]
[Notices]
[Page 5951]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-02544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Division of 
Intramural Research Board of Scientific Counselors, NIAID.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Institute of Allergy and Infectious Diseases, including consideration 
of personnel qualifications and performance, and the competence of 
individual investigators, the disclosure of which would constitute a 
clearly unwarranted invasion of personal privacy.

    Name of Committee: Division of Intramural Research Board of 
Scientific Counselors, NIAID.
    Date: June 8-10, 2026.
    Time: 7:30 a.m. to 10:30 a.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Address: Rocky Mountain Laboratories, National Institute of 
Allergy and Infectious Diseases, National Institutes of Health, 903 
South 4th Street, Building A, Seminar Room, Hamilton, MT 59840.
    Meeting Format: In Person.
    Contact Person: Amy Collins, NIAID Committee Manager, National 
Institute of Allergy and Infectious Diseases, National Institutes of 
Health, 5601 Fishers Lane, Room 4G39, Bethesda, MD 20892, 301-402-
7684, <a href="/cdn-cgi/l/email-protection#f2939f8bdc919d9e9e9b9c81b29c9b9adc959d84"><span class="__cf_email__" data-cfemail="dcbdb1a5f2bfb3b0b0b5b2af9cb2b5b4f2bbb3aa">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: February 5, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-02544 Filed 2-9-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on February 10, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.